Reduced tumorigenesis in mouse mammary cancer cells following inhibition of Pea3- or Erm-dependent transcription

Journal of Cell Science

Volumn 121, Issue 20, 2008, Pages 3393-3402

  Firlej, Virginie ^a   Ladam, Franck ^a   Brysbaert, Guillaume ^b   Dumont, Patrick ^a   Fuks, François ^c   De Launoit, Yvan ^a   Benecke, Arndt ^b   Chotteau Lelievre, Anne ^a  

^a INSTITUT DE BIOLOGIE DE LILLE   (France)

^b INSTITUT DES HAUTES ÉTUDES SCIENTIFIQUES   (France)

^c UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

Mammary tumor; Pea3 Erm; RNAi; Transcription factor; Transcriptome

Indexed keywords

SMALL INTERFERING RNA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR ERM; TRANSCRIPTION FACTOR PEA3; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BREAST CARCINOGENESIS; CANCER CELL; CANCER CELL CULTURE; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CELL STRUCTURE; CONTROLLED STUDY; DOWN REGULATION; EXPERIMENTAL MOUSE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE OVEREXPRESSION; GENE TARGETING; GROWTH INHIBITION; IN VITRO STUDY; MOUSE; NONHUMAN; PHENOTYPIC VARIATION; PRIORITY JOURNAL; RNA INTERFERENCE; TRANSCRIPTION REGULATION; TUMOR GROWTH;

ANIMALS; CELL LINE, TUMOR; DNA-BINDING PROTEINS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; MAMMARY NEOPLASMS, ANIMAL; MICE; MICE, SCID; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; NEOPLASM TRANSPLANTATION; RNA INTERFERENCE; RNA, SMALL INTERFERING; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

MUS;

EID: 56349164360     PISSN: 00219533     EISSN: None     Source Type: Journal    
DOI: 10.1242/jcs.027201     Document Type: Article

References (44)

1. Baert, J. L., Monte, D, Musgrove, E. A., Albagli, O., Sutherland, R. L. and de Launoit, Y. (1997). Expression of the PEA3 group of ETS-related transcription factors in human breast-cancer cells. Int. J. Cancer 70, 590-597.
2. Baert, J. L., Beaudoin, C., Monte, D., Degerny, C., Mauen, S. and de Launoit, Y. (2007). The 26S proteasome system degrades the ERM transcription factor and regulates its transcription-enhancing activity. Oncogene 26, 415-424.
3. Benz, C. C., O'Hagan, R. C., Richter, B., Scott, G. K., Chang, C. H., Xiong, X., Chew, K., Ljung, B. M., Edgerton, S., Thor, A. et al. (1997). HER2/Neu and the Ets transcription activator PEA3 are coordinately upregulated in human breast cancer. Oncogene 15, 1513-1525.
4. Bieche, L, Tozlu, S., Girault, I., Onody, P., Driouch, K, Vidaud, M. and Lidereau, R. (2004). Expression of PEA3/E1AF/ETV4, an Ets-related transcription factor, in breast tumors: positive links to MMP2, NRG1 and CGB expression. Carcinogenesis 25, 405-411.
5. Calderwood, S. K., Khaleque, M. A., Sawyer, D. B. and Ciocca, D. R. (2006). Heat shock proteins in cancer: chaperones of tumorigenesis. Trends Biochem. Sci. 31, 164-172.
6. Chen, J. H., Vercamer, C., Li, Z., Paulin, D., Vandenbunder, B. and Stehelin, D. (1996). PEA3 transactivates vimentin promoter in mammary epithelial and tumor cells. Oncogene 13, 1667-1675.
7. Chen, C., Ouyang, W., Grigura, V., Zhou, Q., Carnes, K., Lira, H., Zhao, G. Q., Arber, S., Kurpios, N., Murphy, T. L. et al. (2005). ERM is required for transcriptional control of the spermatogonial stem cell niche. Nature 436, 1030-1034.
8. Chotteau-Lelievre, A., Desbiens, X, Pelezar, H., Defossez, P. A. and de Launoit, Y. (1997). Differential expression patterns of the PEA3 group transcription factors through murine embryonic development. Oncogene 15, 937-952.
9. Chotteau-Lelievre, A., Dolle, P., Peronne, V., Coutte, L., de Launoit, Y. and Desbiens, X. (2001). Expression patterns of the Ets transcription factors from the PEA3 group during early stages of mouse development. Mech. Dev. 108, 191-195.
10. Chotteau-Lelievre, A., Montesano, R., Soriano, J., Soulie, P., Desbiens, X. and de Launoit, Y. (2003). PEA3 transcription factors are expressed in tissues undergoing branching morphogenesis and promote formation of duct-like structures by mammary epithelial cells in vitro. Dev. Biol. 259, 241-257.
11. Chotteau-Lelievre, A., Revillion, F, Lhotellier, V., Hornez, L., Desbiens, X., Cabaret, V., de Launoit, Y. and Peyrat, J. P. (2004). Prognostic value of ERM gene expression in human primary breast cancers. Clin. Cancer Res. 10, 7297-7303.
12. Davidson, B., Goldberg, I., Tell, L., Vigdorchik, S., Baekelandt, M., Berner, A., Kristensen, G. B., Reich, R. and Kopolovic, J. (2004). The clinical role of the PEA3 transcription factor in ovarian and breast carcinoma in effusions. Clin. Exp. Metastasis 21, 191-199.
13. de Launoit, Y., Baert, J. L., Chotteau-Lelievre, A., Monte, D., Coutte, L., Mauen, S., Firlej, V, Degerny, C. and Verreman, K. (2006). The Ets transcription factors of the PEA3 group: transcriptional regulators in metastasis. Biochim. Biophys. Acta 1766, 79-87.
14. Delannoy-Courdent, A., Mattot, V., Fafeur, V., Fauquette, W., Pollet, I., Calmels, T., Vercamer, C., Boilly, B, Vandenbunder, B. and Desbiens, X. (1998). The expression of an Ets 1 transcription factor lacking its activation domain decreases uPA proteolytic activity and cell motility, and impairs normal tubulogenesis and cancerous scattering in mammary epithelial cells. J. Cell Sci. 111, 1521-1534.
15. Discenza, M. T., Vaz, D., Hassell, J. A. and Pelletier, J. (2004). Activation of the WT1 tumor suppressor gene promoter by Pea3. FEBS Lett. 560, 183-191.
16. El-Tanani, M., Platt-Higgins, A., Rudland, P. S. and Campbell, F. C. (2004). Ets gene PEA3 cooperates with beta-catenin-Lef-1 and c-Jun in regulation of osteopontin transcription. J. Biol. Chem. 279, 20794-20806.
17. Fauquette, V., Perrais, M., Cerulis, S., Jonckheere, N., Ducourouble, M. P., Aubert, J. P., Pigny, P. and Van Seuningen, I. (2005). The antagonistic regulation of human MUC4 and ErbB-2 genes by the Ets protein PEA3 in pancreatic cancer cells: implications for the proliferation/differentiation balance in the cells. Biochem. J. 386, 35-45.
18. Firlej, V., Bocquet, B, Desbiens, X., de Launoit, Y. and Chotteau-Lelievre, A. (2005), Pea3 transcription factor cooperates with USF-1 in regulation of the murine bax transcription without binding to an Ets-binding site. J. Biol. Chem. 280, 887-898.
19. Fleming, F. J., Myers, E., Kelly, G., Crotty, T. B, McDermott, E. W., O'Higgins, N. J., Hill, A. D. and Young, L. S. (2004). Expression of SRC-1, AIB1, and PEA3 in HER2 mediated endocrine resistant breast cancer; a predictive role for SRC-1. J. Clin. Pathol. 57, 1069-1074.
20. Furlan, A., Vercamer, C., Desbiens, X. and Pourtier, A. (2008). Ets-1 triggers and orchestrates the malignant phenotype of mammary cancer cells within their matrix environment. J. Cell Physiol. 215, 782-793.
21. Galang, C. K., Muller, W. J, Foos, G., Oshima, R. G. and Hauser, C. A. (2004). Changes in the expression of many Ets family transcription factors and of potential target genes in normal mammary tissue and tumors. J. Biol. Chem. 279, 11281-11292.
22. Habelhah, H., Okada, F., Kobayashi, M., Nakai, K., Choi, S., Hamada, J., Moriuchi, T., Kaya, M., Yoshida, K., Fujinaga, K. et al. (1999). Increased E1AF expression in mouse fibrosarcoma promotes metastasis through induction of MT1-MMP expression. Oncogene 18, 1771-1776.
23. Hakuma, N., Kinoshita, I., Shimizu, Y, Yamazaki, K., Yoshida, K., Nishimura, M. and Dosaka-Akita, H. (2005). E1AF/PEA3 activates the Rho/Rho-associated kinase pathway to increase the malignancy potential of nun-small-cell lung cancer cells. Cancer Res. 65, 10776-10782.
24. Hanzawa, M., Shindoh, M., Higashino, F., Yasuda, M., Inoue, N., Hida, K., Ono, M., Kohgo, T., Nakamura, M., Notani, K. et al. (2000). Hepatocyte growth factor upregulates E1AF that induces oral squamous cell carcinoma cell invasion by activating matrix metalloproteinase genes. Carcinogenesis 21, 1079-1085.
25. Hida, K., Shindoh, M., Yoshida, K., Kudoh, A., Furaoka, K., Kohgo, T., Fujinaga, K. and Totsuka, Y. (1997). Expression of E1AF, an ets-family transcription factor, is correlated with the invasive phenotype of oral squamous cell carcinoma. Oral Oncol. 33, 426-430.
26. Hiroumi, H., Dosaka-Akita, H., Yoshida, K., Shindoh, M., Ohbuchi, T., Fujinaga, K. and Nishimura, M. (2001). Expression of E1AF/PEA3, an Ets-related transcription factor in human non-small-cell lung cancers: its relevance in cell motility and invasion. Int. J. Cancer 93, 786-791.
27. Jiang, J., Wei, Y., Liu, D., Zhou, J., Shen, J., Chen, X., Zhang, S., Kong, X. and Gu, J. (2007). E1AF promotes breast cancer cell cycle progression via upregulation of Cyclin D3 transcription. Biochem. Biophys. Res. Commun. 358, 53-58.
28. Kaya, M., Yoshida, K., Higashino, F., Mitaka, T., Ishii, S. and Fojinaga, K. (1996). A single ets-related transcription factor, E1AF, confers invasive phenotype on human cancer cells. Oncogene 12, 221-227.
29. Kurpios, N. A., Sabolic, N. A., Shepherd, T. G., Fidalgo, G. M. and Hassell, J. A. (2003). Function of PEA3 Ets transcription factors in mammary gland development and oncogenesis. J. Mammary Gland Biol. Neoplasia 8, 177-190.
30. Laing, M. A., Coonrod, S., Hinton, B. T., Downie, J. W., Tozer, R., Rudnicki, M. A. and Hassell, J. A. (2000). Male sexual dysfunction in mice bearing targeted mutant alleles of the PEA3 ets gene. Mol. Cell. Biol. 20, 9337-9345.
31. Lu, W. C., Liu, Y. N., Kang, B. B. and Chen, J. H. (2003). Trans-activation of heparanase promoter by ETS transcription factors. Oncogene 22, 919-923.
32. Matsui, K., Sugimori, K., Motomura, H., Ejiri, N., Tsukada, K. and Kitajima, I. (2006). PEA3 cooperates with c-Jun in regulation of HER2/ neu transcription. Oncol. Rep. 16, 153-1584
33. Moss, A. C., Lawlor, G, Murray, D., Tighe, D., Madden, S. F., Mulligan, A. M, Keane, C. O., Brady, H. R., Doran, P. P. and Macmathuna, P. (2006). ETV4 and Myeov knockdown impairs colon cancer cell hue proliferation and invasion. Biochem. Biophys. Res. Commun. 345, 216-221.
34. Myers, E., Hill, A. D., Kelly, G., McDermott, E. W., O'Higgins, N, J. and Young, L. S. (2006). A positive role for PEA3 in HER2-mediated breast tumour progression. Br. J. Cancer 95, 1404-1409.
35. Nelson, C. M. and Bissell, M. J. (2005). Modeling dynamic reciprocity: engineering three-dimensional culture models of breast architecture, function, and neoplastic transformation. Semin. Cancer Biol. 15, 342-352.
36. Noth, S. and Benecke, A. (2005). Avoiding inconsistencies over time and tracking difficulties in Applied Biosystems AB1700/Panther probe-to-gene annotations. BMC Bioinformatics 6, 307.
37. Noth, S., Brysbaert, G. and Benecke, A. (2006a). Normalization using weighted negative second order exponential error functions (NeONORM) provides robustness against asymmetries in comparative transcriptome profiles and avoids false calls. Genomics Proteomics Bioinformatics 4, 90-109.
38. Noth, S., Brysbaert, G., Pellay, F. X. and Benecke, A. (2006b). High-sensitivity transcriptome data structure and implications for analysis and biologic interpretation. Genomics Proteomics Bioinformatics 4, 212-229.
39. Shepherd, T. and Hassell, J. A. (2001). Role of Ets transcription factors in mammary gland development and oncogenesis. J. Mammary Gland Biol. Neoplasia 6, 129-140.
40. Shepherd, T. G., Kockeritz, L., Szrajber, M. R., Muller, W. J. and Hassell, J. A. (2001). The pea3 subfamily ets genes are required for HER2/Neu-mediated mammary oncogenesis. Curr Biol. 11, 1739-1748.
41. Shindoh, M., Higashino, F. and Kohgo, T. (2004). E1AF, an ets-oncogene family transcription factor. Cancer Lett. 216, 1-8.
42. Soriano, J. V., Pepper, M. S., Nakamura, T, Orci, L. and Montesano, R. (1995). Hepatocyte growth factor stimulates extensive development of branching duct-like structures by cloned mammary gland epithelial cells. J. Cell Sci. 108, 413-430.
43. Upadhyay, S., Liu, C., Chatterjee, A., Hoque, M. O., Kim, M. S., Engles, J., Westra, W., Trink, B., Ratovitski, E. and Sidransky, D. (2006). LKB1/STK11 Suppresses Cyclooxygenase-2 Induction and Cellular Invasion through PEA3 in Lung Cancer. Cancer Res. 66, 7870-7879.
44. Xing, X., Wang, S. C., Xia, W., Zou, Y., Shao, R., Kwong, K. Y., Yu, Z., Zhang, S., Miller, S., Huang, L. et al. (2000). The ets protein PEA3 suppresses HER-2/neu overexpression and inhibits tumorigenesis. Nat. Med. 6, 189-195.